Global Protein Binding Assays Market – Industry Analysis and Forecast (2020-2027) – By Technology, End User and Region.

Market Scenario

Protein Binding Assays Market size was valued US$ XX Mn in 2019 and the total revenue is expected to grow at 10.4% through 2020 to 2027. Protein Binding Assays Market Market Overview Protein binding assay is used to measure interactions between two molecules, such as protein binding another protein, a small molecule, or nucleic acid. The protein binding assay is gradually being accepted in the preclinical stages of drug discovery & development programs. According to U.S. FDA, 4 novel therapeutics and biologics were approved by the Center for Drug Evaluation and Research (CDER) in 2020 as compared to 48 new drugs approved in 2019. So, the surge in the number of drug candidates being screened and sanctioned annually drives the acceptance of protein binding assays. Drug discovery & development is cost-intensive and requires high capital investment, technological capabilities, and human resources. During the development stages, manufacturers suffer a considerable loss if a drug candidate fails.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Protein Binding Assays market Drivers and Restraints: The protein binding assay is a widely used process for new drug development. The growth of the protein binding assays market is XX % increased by the development of various advanced technologies utilized for protein binding. The many pharmaceutical and biotechnology companies are concentrating on new drug developments that leading to a growth in drug discovery activities. Increasing focus on reduction of the costs being experienced on the drug discovery and their manufacturing is the major factor expected to propel the growth of the market. In situ protein-protein interaction assay is more sensitive method than other conventional, methods, which anticipated to boost execution of these assays in laboratories as an advanced method. However, the Shortage of information and skills related to the application of protein binding assays is another factor restricting this market growth. Concerns regarding various complications associated with technology available, which is to be used in combination with these products is anticipated to hamper the growth of the market. For instance, in (April 5, 2019) Calixar announces a collaborative research agreement with Thermo Fisher Scientific on multiple membrane proteins of high relevance to drug discovery. The protein binding market is segmented into Technology, End user and Application. Based on the technology, Equilibrium dialysis market has largest share and dominating the protein binding assays market because of its simplicity, low costs, and high accuracy. North America accounted for the largest share in the protein binding assays market because of funds provided from public and private entities for drug discovery and development. A number of conferences on pharma research such as, 2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry was scheduled on May 30-31, 2019 at Orlando also boost the regional growth. Asia Pacific region is anticipated to see highest growth for protein binding assays market because of initiatives undertaken by agencies to transform drug discovery & development programs and low cost of preclinical methods ,which helps to outsource the services to the region. The objective of the report is to present a comprehensive analysis of the Global Protein Binding Assays Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by Region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by Region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Protein Binding Assays Market dynamics, structure by analyzing the market segments and project the Global Protein Binding Assays Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Protein Binding Assays Market make the report investor’s guide.

Scope of the Global Protein Binding Assays Market

Global Protein Binding Assays Market, by Technology

• Equilibrium dialysis • Ultrafiltration • Ultracentrifugation • Other technologies

Global Protein Binding Assays Market, by End User

• Pharmaceutical & biotechnology companies • Contract research organizations (CROs) • Other end users (academic institutes and government organizations)

Global Protein Binding Assays Market, by Regions

• North America • Asia-Pacific • Europe • Latin America • Middle East and Africa (MEA)

Key players

• Thermo Fisher Scientific (US) • Charles River • GE Healthcare (US) • Danaher (US) • Sovicell GMBH • Absorption Systems LLC • GE Healthcare • Eurofins Scientific • 3B Pharmaceuticals • Creative Biolabs • Evotec (Cyprotex) • Bioduro • Sartorius Stedim BioOutsource Limited • Bio-Rad Laboratories, Inc. • nanoComposix; Abzena Ltd • Abcam plc • GVK Biosciences Private Limited • Promega Corporation

Table of Contents

Global Protein Binding Assays Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Protein Binding Assays Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Protein Binding Assays Market Analysis and Forecast 6.1. Protein Binding Assays Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Protein Binding Assays Market Analysis and Forecast, by Technology 7.1. Introduction and Definition 7.2. Key Findings 7.3. Protein Binding Assays Market Value Share Analysis, by Technology 7.4. Protein Binding Assays Market Size (US$ Bn) Forecast, by Technology 7.5. Protein Binding Assays Market Analysis, by Technology 7.6. Protein Binding Assays Market Attractiveness Analysis, by Technology 8. Global Protein Binding Assays Market Analysis and Forecast, by End User 8.1. Introduction and Definition 8.2. Key Findings 8.3. Protein Binding Assays Market Value Share Analysis, by End User 8.4. Protein Binding Assays Market Size (US$ Bn) Forecast, by End User 8.5. Protein Binding Assays Market Analysis, by End User 8.6. Protein Binding Assays Market Attractiveness Analysis, by End User 9. Global Protein Binding Assays Market Analysis, by Region 9.1. Protein Binding Assays Market Value Share Analysis, by Region 9.2. Protein Binding Assays Market Size (US$ Bn) Forecast, by Region 9.3. Protein Binding Assays Market Attractiveness Analysis, by Region 10. North America Protein Binding Assays Market Analysis 10.1. Key Findings 10.2. North America Protein Binding Assays Market Overview 10.3. North America Protein Binding Assays Market Value Share Analysis, by Technology 10.4. North America Protein Binding Assays Market Forecast, by Technology 10.4.1. Equilibrium dialysis 10.4.2. Ultrafiltration 10.4.3. Ultracentrifugation 10.4.4. Other technologies 10.5. North America Protein Binding Assays Market Value Share Analysis, by End User 10.6. North America Protein Binding Assays Market Forecast, by End User 10.6.1. Pharmaceutical & biotechnology companies 10.6.2. Contract research organizations (CROs) 10.6.3. Other end users (academic institutes and government organizations) 10.7. North America Protein Binding Assays Market Value Share Analysis, by Country 10.8. North America Protein Binding Assays Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Protein Binding Assays Market Analysis, by Country 10.10. U.S. Protein Binding Assays Market Forecast, by Technology 10.10.1. Equilibrium dialysis 10.10.2. Ultrafiltration 10.10.3. Ultracentrifugation 10.10.4. Other technologies 10.11. U.S. Protein Binding Assays Market Forecast, by End User 10.11.1. Pharmaceutical & biotechnology companies 10.11.2. Contract research organizations (CROs) 10.11.3. Other end users (academic institutes and government organizations) 10.12. Canada Protein Binding Assays Market Forecast, by Technology 10.12.1. Equilibrium dialysis 10.12.2. Ultrafiltration 10.12.3. Ultracentrifugation 10.12.4. Other technologies 10.13. Canada Protein Binding Assays Market Forecast, by End User 10.13.1. Pharmaceutical & biotechnology companies 10.13.2. Contract research organizations (CROs) 10.13.3. Other end users (academic institutes and government organizations) 10.14. North America Protein Binding Assays Market Attractiveness Analysis 10.14.1. By Technology 10.14.2. By End User 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Protein Binding Assays Market Analysis 11.1. Key Findings 11.2. Europe Protein Binding Assays Market Overview 11.3. Europe Protein Binding Assays Market Value Share Analysis, by Technology 11.4. Europe Protein Binding Assays Market Forecast, by Technology 11.4.1. Equilibrium dialysis 11.4.2. Ultrafiltration 11.4.3. Ultracentrifugation 11.4.4. Other technologies 11.5. Europe Protein Binding Assays Market Value Share Analysis, by End User 11.6. Europe Protein Binding Assays Market Forecast, by End User 11.6.1. Pharmaceutical & biotechnology companies 11.6.2. Contract research organizations (CROs) 11.6.3. Other end users (academic institutes and government organizations) 11.7. Europe Protein Binding Assays Market Value Share Analysis, by Country 11.8. Europe Protein Binding Assays Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Protein Binding Assays Market Analysis, by Country 11.10. Germany Protein Binding Assays Market Forecast, by Technology 11.10.1. Equilibrium dialysis 11.10.2. Ultrafiltration 11.10.3. Ultracentrifugation 11.10.4. Other technologies 11.11. Germany Protein Binding Assays Market Forecast, by End User 11.11.1. Pharmaceutical & biotechnology companies 11.11.2. Contract research organizations (CROs) 11.11.3. Other end users (academic institutes and government organizations) 11.12. U.K. Protein Binding Assays Market Forecast, by Technology 11.12.1. Equilibrium dialysis 11.12.2. Ultrafiltration 11.12.3. Ultracentrifugation 11.12.4. Other technologies 11.13. U.K. Protein Binding Assays Market Forecast, by End User 11.13.1. Pharmaceutical & biotechnology companies 11.13.2. Contract research organizations (CROs) 11.13.3. Other end users (academic institutes and government organizations) 11.14. France Protein Binding Assays Market Forecast, by Technology 11.14.1. Equilibrium dialysis 11.14.2. Ultrafiltration 11.14.3. Ultracentrifugation 11.14.4. Other technologies 11.15. France Protein Binding Assays Market Forecast, by End User 11.15.1. Pharmaceutical & biotechnology companies 11.15.2. Contract research organizations (CROs) 11.15.3. Other end users (academic institutes and government organizations) 11.16. Italy Protein Binding Assays Market Forecast, by Technology 11.16.1. Equilibrium dialysis 11.16.2. Ultrafiltration 11.16.3. Ultracentrifugation 11.16.4. Other technologies 11.17. Italy Protein Binding Assays Market Forecast, by End User 11.17.1. Pharmaceutical & biotechnology companies 11.17.2. Contract research organizations (CROs) 11.17.3. Other end users (academic institutes and government organizations) 11.18. Spain Protein Binding Assays Market Forecast, by Technology 11.18.1. Equilibrium dialysis 11.18.2. Ultrafiltration 11.18.3. Ultracentrifugation 11.18.4. Other technologies 11.19. Spain Protein Binding Assays Market Forecast, by End User 11.19.1. Pharmaceutical & biotechnology companies 11.19.2. Contract research organizations (CROs) 11.19.3. Other end users (academic institutes and government organizations) 11.20. Rest of Europe Protein Binding Assays Market Forecast, by Technology 11.20.1. Equilibrium dialysis 11.20.2. Ultrafiltration 11.20.3. Ultracentrifugation 11.20.4. Other technologies 11.21. Rest of Europe Protein Binding Assays Market Forecast, by End User 11.21.1. Pharmaceutical & biotechnology companies 11.21.2. Contract research organizations (CROs) 11.21.3. Other end users (academic institutes and government organizations) 11.22. Europe Protein Binding Assays Market Attractiveness Analysis 11.22.1. By Technology 11.22.2. By End User 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Protein Binding Assays Market Analysis 12.1. Key Findings 12.2. Asia Pacific Protein Binding Assays Market Overview 12.3. Asia Pacific Protein Binding Assays Market Value Share Analysis, by Technology 12.4. Asia Pacific Protein Binding Assays Market Forecast, by Technology 12.4.1. Equilibrium dialysis 12.4.2. Ultrafiltration 12.4.3. Ultracentrifugation 12.4.4. Other technologies 12.5. Asia Pacific Protein Binding Assays Market Value Share Analysis, by End User 12.6. Asia Pacific Protein Binding Assays Market Forecast, by End User 12.6.1. Pharmaceutical & biotechnology companies 12.6.2. Contract research organizations (CROs) 12.6.3. Other end users (academic institutes and government organizations) 12.7. Asia Pacific Protein Binding Assays Market Value Share Analysis, by Country 12.8. Asia Pacific Protein Binding Assays Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Protein Binding Assays Market Analysis, by Country 12.10. China Protein Binding Assays Market Forecast, by Technology 12.10.1. Equilibrium dialysis 12.10.2. Ultrafiltration 12.10.3. Ultracentrifugation 12.10.4. Other technologies 12.11. China Protein Binding Assays Market Forecast, by End User 12.11.1. Pharmaceutical & biotechnology companies 12.11.2. Contract research organizations (CROs) 12.11.3. Other end users (academic institutes and government organizations) 12.12. India Protein Binding Assays Market Forecast, by Technology 12.12.1. Equilibrium dialysis 12.12.2. Ultrafiltration 12.12.3. Ultracentrifugation 12.12.4. Other technologies 12.13. India Protein Binding Assays Market Forecast, by End User 12.13.1. Pharmaceutical & biotechnology companies 12.13.2. Contract research organizations (CROs) 12.13.3. Other end users (academic institutes and government organizations) 12.14. Japan Protein Binding Assays Market Forecast, by Technology 12.14.1. Equilibrium dialysis 12.14.2. Ultrafiltration 12.14.3. Ultracentrifugation 12.14.4. Other technologies 12.15. Japan Protein Binding Assays Market Forecast, by End User 12.15.1. Pharmaceutical & biotechnology companies 12.15.2. Contract research organizations (CROs) 12.15.3. Other end users (academic institutes and government organizations) 12.16. ASEAN Protein Binding Assays Market Forecast, by Technology 12.16.1. Equilibrium dialysis 12.16.2. Ultrafiltration 12.16.3. Ultracentrifugation 12.16.4. Other technologies 12.17. ASEAN Protein Binding Assays Market Forecast, by End User 12.17.1. Pharmaceutical & biotechnology companies 12.17.2. Contract research organizations (CROs) 12.17.3. Other end users (academic institutes and government organizations) 12.18. Rest of Asia Pacific Protein Binding Assays Market Forecast, by Technology 12.18.1. Equilibrium dialysis 12.18.2. Ultrafiltration 12.18.3. Ultracentrifugation 12.18.4. Other technologies 12.19. Rest of Asia Pacific Protein Binding Assays Market Forecast, by End User 12.19.1. Pharmaceutical & biotechnology companies 12.19.2. Contract research organizations (CROs) 12.19.3. Other end users (academic institutes and government organizations) 12.20. Asia Pacific Protein Binding Assays Market Attractiveness Analysis 12.20.1. By Technology 12.20.2. By End User 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Protein Binding Assays Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Protein Binding Assays Market Overview 13.3. Middle East & Africa Protein Binding Assays Market Value Share Analysis, by Technology 13.4. Middle East & Africa Protein Binding Assays Market Forecast, by Technology 13.4.1. Equilibrium dialysis 13.4.2. Ultrafiltration 13.4.3. Ultracentrifugation 13.4.4. Other technologies 13.5. Middle East & Africa Protein Binding Assays Market Value Share Analysis, by End User 13.6. Middle East & Africa Protein Binding Assays Market Forecast, by End User 13.6.1. Pharmaceutical & biotechnology companies 13.6.2. Contract research organizations (CROs) 13.6.3. Other end users (academic institutes and government organizations) 13.7. Middle East & Africa Protein Binding Assays Market Value Share Analysis, by Country 13.8. Middle East & Africa Protein Binding Assays Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Protein Binding Assays Market Analysis, by Country 13.10. GCC Protein Binding Assays Market Forecast, by Technology 13.10.1. Equilibrium dialysis 13.10.2. Ultrafiltration 13.10.3. Ultracentrifugation 13.10.4. Other technologies 13.11. GCC Protein Binding Assays Market Forecast, by End User 13.11.1. Pharmaceutical & biotechnology companies 13.11.2. Contract research organizations (CROs) 13.11.3. Other end users (academic institutes and government organizations) 13.12. South Africa Protein Binding Assays Market Forecast, by Technology 13.12.1. Equilibrium dialysis 13.12.2. Ultrafiltration 13.12.3. Ultracentrifugation 13.12.4. Other technologies 13.13. South Africa Protein Binding Assays Market Forecast, by End User 13.13.1. Pharmaceutical & biotechnology companies 13.13.2. Contract research organizations (CROs) 13.13.3. Other end users (academic institutes and government organizations) 13.14. Rest of Middle East & Africa Protein Binding Assays Market Forecast, by Technology 13.14.1. Equilibrium dialysis 13.14.2. Ultrafiltration 13.14.3. Ultracentrifugation 13.14.4. Other technologies 13.15. Rest of Middle East & Africa Protein Binding Assays Market Forecast, by End User 13.15.1. Pharmaceutical & biotechnology companies 13.15.2. Contract research organizations (CROs) 13.15.3. Other end users (academic institutes and government organizations) 13.16. Middle East & Africa Protein Binding Assays Market Attractiveness Analysis 13.16.1. By Technology 13.16.2. By End User 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Protein Binding Assays Market Analysis 14.1. Key Findings 14.2. South America Protein Binding Assays Market Overview 14.3. South America Protein Binding Assays Market Value Share Analysis, by Technology 14.4. South America Protein Binding Assays Market Forecast, by Technology 14.4.1. Equilibrium dialysis 14.4.2. Ultrafiltration 14.4.3. Ultracentrifugation 14.4.4. Other technologies 14.5. South America Protein Binding Assays Market Value Share Analysis, by End User 14.6. South America Protein Binding Assays Market Forecast, by End User 14.6.1. Pharmaceutical & biotechnology companies 14.6.2. Contract research organizations (CROs) 14.6.3. Other end users (academic institutes and government organizations) 14.7. South America Protein Binding Assays Market Value Share Analysis, by Country 14.8. South America Protein Binding Assays Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Protein Binding Assays Market Analysis, by Country 14.10. Brazil Protein Binding Assays Market Forecast, by Technology 14.10.1. Equilibrium dialysis 14.10.2. Ultrafiltration 14.10.3. Ultracentrifugation 14.10.4. Other technologies 14.11. Brazil Protein Binding Assays Market Forecast, by End User 14.11.1. Pharmaceutical & biotechnology companies 14.11.2. Contract research organizations (CROs) 14.11.3. Other end users (academic institutes and government organizations) 14.12. Mexico Protein Binding Assays Market Forecast, by Technology 14.12.1. Equilibrium dialysis 14.12.2. Ultrafiltration 14.12.3. Ultracentrifugation 14.12.4. Other technologies 14.13. Mexico Protein Binding Assays Market Forecast, by End User 14.13.1. Pharmaceutical & biotechnology companies 14.13.2. Contract research organizations (CROs) 14.13.3. Other end users (academic institutes and government organizations) 14.14. Rest of South America Protein Binding Assays Market Forecast, by Technology 14.14.1. Equilibrium dialysis 14.14.2. Ultrafiltration 14.14.3. Ultracentrifugation 14.14.4. Other technologies 14.15. Rest of South America Protein Binding Assays Market Forecast, by End User 14.15.1. Pharmaceutical & biotechnology companies 14.15.2. Contract research organizations (CROs) 14.15.3. Other end users (academic institutes and government organizations) 14.16. South America Protein Binding Assays Market Attractiveness Analysis 14.16.1. By Technology 14.16.2. By End User 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Vehicles and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Vehicles 15.2.3.2. M&A Key Players, Forward Integration and Backward 15.2.3.3. Integration 15.3. Company Profiles: Key Players 15.3.1. Thermo Fisher Scientific (US) 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Charles River 15.3.3. GE Healthcare (US) 15.3.4. Danaher (US) 15.3.5. Sovicell GMBH 15.3.6. Absorption Systems LLC 15.3.7. GE Healthcare 15.3.8. Eurofins Scientific 15.3.9. 3B Pharmaceuticals 15.3.10. Creative Biolabs 15.3.11. Evotec (Cyprotex) 15.3.12. Bioduro 15.3.13. Sartorius Stedim BioOutsource Limited 15.3.14. Bio-Rad Laboratories, Inc. 15.3.15. nanoComposix; Abzena Ltd 16. Primary Key Insight

About This Report

Report ID 53201
Category Biotechnology
Published Date Feb 2020
No of Pages 183
Contact Us